The Swedish scientist behind the Alzheimer’s drug has big ambitions
As Japanese drugmaker Eisai this week presented data confirming it had developed the first drug to slow cognitive decline in Alzheimer’s patients, audiences at a conference in San Francisco erupted in applause. Among those present was Lars Lannfelt, a little-known Swedish scientist who invented the breakthrough drug, known as lecanemab, and will make a fortune …
The Swedish scientist behind the Alzheimer’s drug has big ambitions Read More »